- pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy.
Jin Qu et al, 2017, Acta Biomater CrossRef - null
Anfal Jasim et al, 2017 CrossRef - null
Muhammad Raza Shah et al, 2017 CrossRef - Size Tunable Core Crosslinked Micelles from HPMA-Based Amphiphilic Block Copolymers
Stefan Kramer et al, 2017, Macromol. Chem. Phys. CrossRef - Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy
YAN-JUN ZHONG et al, 2013 CrossRef - Parameters Affecting the Enhanced Permeability and Retention Effect: The Need for Patient Selection
Az Alddien Natfji et al, 2017, Journal of Pharmaceutical Sciences CrossRef - Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment
Chun Y. Wong et al, 2017, Journal of Controlled Release CrossRef - Polymer therapeutics and the EPR effect
Hiroshi Maeda, 2017, Journal of Drug Targeting CrossRef - FRET Imaging of Enzyme-Responsive HPMA Copolymer Conjugate.
Rui Zhang et al, 2017, Macromol Biosci CrossRef - Doxorubicin: nanotechnological overviews from bench to bedside.
Maximiliano Cagel et al, 2017, Drug Discov Today CrossRef - null
S.P. Egusquiaguirre et al, 2016 CrossRef - Glutathione-Sensitive Hyaluronic Acid-SS-Mertansine Prodrug with a High Drug Content: Facile Synthesis and Targeted Breast Tumor Therapy.
Ping Zhong et al, 2016, Biomacromolecules CrossRef - Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies
Karel Ulbrich et al, 2016, Chem. Rev. CrossRef - Rethinking cancer nanotheranostics.
Hongmin Chen et al, 2017, Nat Rev Mater CrossRef - Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomes.
Esther Tahover et al, 0 CrossRef - Direct Cytoplasmic Delivery and Nuclear Targeting Delivery of HPMA-MT Conjugates in a Microtubules Dependent Fashion.
Jiaju Zhong et al, 2016, Mol Pharm CrossRef - null
Dalit Landesman-Milo et al, 2016 CrossRef - Antibody-targeted biodegradable nanoparticles for cancer therapy.
Vahid Heravi Shargh et al, 2016, Nanomedicine (Lond) CrossRef - αvβ3 Integrin-targeted reduction-sensitive micellar mertansine prodrug: Superb drug loading, enhanced stability, and effective inhibition of melanoma growth in vivo.
Ping Zhong et al, 2017, J Control Release CrossRef - Developments and future clinical outlook of taxane nanomedicines.
Benoit Louage et al, 2017, J Control Release CrossRef - Clinical advances of nanocarrier-based cancer therapy and diagnostics.
Edurne Luque-Michel et al, 2017, Expert Opin Drug Deliv CrossRef - Nanomedicine as an emerging platform for metastatic lung cancer therapy
Dalit Landesman-Milo et al, 2015, Cancer Metastasis Rev CrossRef - A novel nanomissile targeting two biomarkers and accurately bombing CTCs with doxorubicin.
Yu Gao et al, 2017, Nanoscale CrossRef - A tumor-targeted polymer theranostics platform for positron emission tomography and fluorescence imaging.
Eva Koziolová et al, 2017, Nanoscale CrossRef - Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
Min Liu et al, 2016, J Control Release CrossRef - Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Edgar Pérez-Herrero et al, 2015, Eur J Pharm Biopharm CrossRef - Status and trends in the development of clinical diagnostic agents.
Tatjana Opacic et al, 2017, Wiley Interdiscip Rev Nanomed Nanobiotechnol CrossRef - Preclinical imaging and translational animal models of cancer for accelerated clinical implementation of nanotechnologies and macromolecular agents
Raquel De Souza et al, 2015, Journal of Controlled Release CrossRef - Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications.
Andreas Wicki et al, 2015, J Control Release CrossRef - Preclinical safety assessments of nano-sized constructs on cardiovascular system toxicity: A case for telemetry.
Hoay Yan Cheah et al, 2017, J Appl Toxicol CrossRef - Hemodynamic effects of HPMA copolymer based doxorubicin conjugate: A randomized controlled and comparative spectral study in conscious rats.
Hoay Yan Cheah et al, 2017, Nanotoxicology CrossRef - Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents
Raul C Maranhão et al, 2017, Expert Opinion on Drug Delivery CrossRef - Combination antitumor therapy with targeted dual-nanomedicines
Wenbing Dai et al, 2017, Advanced Drug Delivery Reviews CrossRef - Current and evolving approaches for improving the oral permeability of BCS Class III or analogous molecules.
Vivek S Dave et al, 2017, Drug Dev Ind Pharm CrossRef - Therapeutic potential of carbohydrate-based polymeric and nanoparticle systems
Rajesh Sunasee et al, 2014, Expert Opinion on Drug Delivery CrossRef - Emerging Therapeutic Potential of Nanoparticles in Pancreatic Cancer: A Systematic Review of Clinical Trials
Minnie Au et al, 2016, Biomedicines CrossRef - Efficient Tumor Accumulation, Penetration and Tumor Growth Inhibition Achieved by Polymer Therapeutics: The Effect of Polymer Architectures.
Tong Shen et al, 2017, Biomacromolecules CrossRef - HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release.
Petr Chytil et al, 2018, Macromol Biosci CrossRef - In Vitro Synergistic Action of Geldanamycin- and Docetaxel-Containing HPMA Copolymer-RGDfK Conjugates Against Ovarian Cancer
Nate Larson et al, 2014, Macromol. Biosci. CrossRef - Biodegradable Polymersomes as Nanocarriers for Doxorubicin Hydrochloride: Enhanced Cytotoxicity in MCF-7/ADR Cells and Prolonged Blood Circulation
Yanhui Chao et al, 2017, Pharm Res CrossRef - null
Daniel Merk et al, 2017 CrossRef - null
Yerra Rajeshwar, 2017 CrossRef - Leveraging Physiology for Precision Drug Delivery
Wujin Sun et al, 2017, Physiological Reviews CrossRef - Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM–camptothecin conjugate
Pengkai Ma et al, 2018, Drug Delivery CrossRef - Anticancer effects of Ac-Phe-Lys-PABC-doxorubicin via mitochondria-centered apoptosis involving reactive oxidative stress and the ERK1/2 signaling pathway in MGC-803 cells
YAN-JUN ZHONG et al, 2013 CrossRef - Polymer-Based Prodrugs: Improving Tumor Targeting and the Solubility of Small Molecule Drugs in Cancer Therapy
Sonja Dragojevic et al, 2015, Molecules CrossRef - Metabolomics facilitates the discrimination of the specific anti-cancer effects of free- and polymer-conjugated doxorubicin in breast cancer models
Ana Armiñán et al, 2018, Biomaterials CrossRef - The expanding role of prodrugs in contemporary drug design and development
Jarkko Rautio et al, 2018, Nat Rev Drug Discov CrossRef - Nanoformulations of doxorubicin: how far have we come and where do we go from here?
Ivana Borišev et al, 2018, Nanotechnology CrossRef - null
Junqing Wang et al, 2018 CrossRef - null
Matthew Parrott et al, 2018 CrossRef - Responsive polymer conjugates for drug delivery applications: recent advances in bioconjugation methodologies
Daniel Cristian Ferreira Soares et al, 2018, Journal of Drug Targeting CrossRef - null
Miguel Moreno Raja et al, 2019 CrossRef - Nanomedicines for Malaria Chemotherapy: Encapsulation vs. Polymer Therapeutics
Sindisiwe Mvango et al, 2018, Pharm Res CrossRef - Polymer–drug conjugate therapeutics: advances, insights and prospects
Iriny Ekladious et al, 2018, Nat Rev Drug Discov CrossRef - Cathepsin-sensitive nanoscale drug delivery systems for cancer therapy and other diseases
Divya Dheer et al, 2019, Advanced Drug Delivery Reviews CrossRef - null
Matthew Parrott et al, 2019 CrossRef - null
Katia Maso et al, 2019 CrossRef - null
Alberto Gabizon et al, 2011 CrossRef - null
Sebastien Taurin et al, 2013 CrossRef - null
Cristina Fante et al, 2013 CrossRef - null
Mitulkumar A. Patel et al, 2014 CrossRef - null
Jurjen S. Lagas et al, 2014 CrossRef - null
Anjan Kumar Mohanty et al, 2015 CrossRef - GRP78‐Targeted HPMA Copolymer‐Photosensitizer Conjugate for Hyperthermia‐Induced Enhanced Uptake and Cytotoxicity in MCF‐7 Breast Cancer Cells
Gantumur Battogtokh et al, 2019, Macromol. Biosci. CrossRef - null
Maricla Galetti et al, 2019 CrossRef - Induction of anti-cancer T cell immunity by in situ vaccination using systemically administered nanomedicines
Geoffrey M. Lynn et al, 2019, Cancer Letters CrossRef - Modifying the Body Distribution of HPMA-Based Copolymers by Molecular Weight and Aggregate Formation
Mareli Allmeroth et al, 2011, Biomacromolecules CrossRef - null
Mohd Jahir Khan et al, 2019 CrossRef - Prodrugs as drug delivery system in oncology
J. Delahousse et al, 2019, Cancer Chemother Pharmacol CrossRef - Clinical developments of antitumor polymer therapeutics
Shazia Parveen et al, 2019, RSC Adv. CrossRef - Interaction of N-(2-Hydroxypropyl)methacrylamide Copolymer-Doxorubicin Conjugates with Human Liver Microsomal Cytochromes P450: Comparison with Free Doxorubicin
Vlastimil Mašek et al, 2011, Drug Metab Dispos CrossRef - Polymer-functionalized mesoporous carbon nanoparticles on overcoming multiple barriers and improving oral bioavailability of Probucol
Hongyan Lu et al, 2019, Carbohydrate Polymers CrossRef - Identification of Potential Inhibitors of Cathepsin‐B using Shape & Pharmacophore‐based Virtual Screening, Molecular Docking and Explicit Water Thermodynamics
Tanuj Sharma et al, 2019, Mol. Inf. CrossRef - A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the market
Mara Gonçalves et al, 2019, Journal of Controlled Release CrossRef - null
Mala Trivedi et al, 2020 CrossRef - Identifying “Many-to-Many” Relationships Between Gene-Expression Data and Drug-Response Data Via Sparse Binary Matching
Jiulun Cai et al, 2019, IEEE/ACM Trans. Comput. Biol. and Bioinf. CrossRef - A Novel pH-Tunable Secondary Conformation Containing Mixed Micellar System in Anticancer Treatment
Fu-Ying Shih et al, 2020, Cancers CrossRef - Biotinylated HPMA centered polymeric nanoparticles for Bortezomib delivery
Sarita Rani et al, 2020, International Journal of Pharmaceutics CrossRef - Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
Nataša Avramović et al, 2020, Pharmaceutics CrossRef - HPMA-based polymeric conjugates in anticancer therapeutics
Sarita Rani et al, 2020, Drug Discovery Today CrossRef - Polymer-Drug Conjugate, a Potential Therapeutic to Combat Breast and Lung Cancer
Sibusiso Alven et al, 2020, Pharmaceutics CrossRef - Poly(2-methyl-2-oxazoline) conjugates with doxorubicin: From synthesis of high drug loading water-soluble constructs to in vitro anti-cancer properties
Ondrej Sedlacek et al, 2020, Journal of Controlled Release CrossRef - Cancer Nanomedicine Special Issue Review Anticancer Drug Delivery with Nanoparticles: Extracellular Vesicles or Synthetic Nanobeads as Therapeutic Tools for Conventional Treatment or Immunotherapy
Maria Raffaella Zocchi et al, 2020, Cancers CrossRef - Polymer nanomedicines
Jindřich Kopeček et al, 2020, Advanced Drug Delivery Reviews CrossRef - Doxorubicin-loaded composite nanogels for cancer treatment
Marzieh Mohammadi et al, 2020, Journal of Controlled Release CrossRef - Recent developments in targeting genes and pathways by RNAi‐based approaches in colorectal cancer
Asiyeh Jebelli et al, 2020, Med Res Rev CrossRef - HPMA–Copolymer Nanocarrier Targets Tumor-Associated Macrophages in Primary and Metastatic Breast Cancer
Melissa N. Zimel et al, 2017, Mol Cancer Ther CrossRef - Polyvinyl Alcohol Carbazate as a Polymer-Based Antitumoral Agent
Felix Sellberg et al, 2021, Front. Oncol. CrossRef - Supramolecular cancer nanotheranostics
Jiong Zhou et al, 2021, Chem. Soc. Rev. CrossRef - Review of the Mechanism of Nanocarriers and Technological Developments in the Field of Nanoparticles for Applications in Cancer Theragnostics
Nehil Shreyash et al, 2021, ACS Appl. Bio Mater. CrossRef - null
Mohammed O. Balogun et al, 2021 CrossRef - Rational nanocarrier design towards clinical translation of cancer nanotherapy
Dandan Guo et al, 2021, Biomed. Mater. CrossRef - The Past, Present, and Future of Breast Cancer Models for Nanomedicine Development
Paz Boix-Montesinos et al, 2021, Advanced Drug Delivery Reviews CrossRef - Polymer−Drug Conjugates for Combination Anticancer Therapy: Investigating the Mechanism of Action
Gianfranco Pasut et al, 2009, J. Med. Chem. CrossRef - Polymer‐Based Drug‐Free Therapeutics for Anticancer, Anti‐Inflammatory, and Antibacterial Treatment
Marina Rodrigues Tavares et al, 2021, Macromol. Biosci. CrossRef - Molecular Perspective of Nanoparticle Mediated Therapeutic Targeting in Breast Cancer: An Odyssey of Endoplasmic Reticulum Unfolded Protein Response (UPRER) and Beyond
Safikur Rahman et al, 2021, Biomedicines CrossRef - Remodeling tumor microenvironment with nanomedicines
John D. Martin et al, 2021, WIREs Nanomed Nanobiotechnol CrossRef - Vinyl Polymer-based technologies towards the efficient delivery of chemotherapeutic drugs
Patrícia Pereira et al, 2021, Progress in Polymer Science CrossRef - Comparison of Hydrazone Heterobifunctional Cross-Linking Agents for Reversible Conjugation of Thiol-Containing Chemistry
R. James Christie et al, 2010, Bioconjugate Chem. CrossRef - Research progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy
Muhammad Sohail et al, 2021, Expert Review of Anticancer Therapy CrossRef - Nanomedicines: Recent Progress, Impact and Challenges in Applications
Aditi Singh, 2021, Asian J. Chem. CrossRef - Synthesis, Morphology, and Rheological Evaluation of HPMA (N-2-Hydroxypropyl Methacrylamide)-PCL (Polycaprolactone) Conjugates
Sarita Rani et al, 2021, ACS Omega CrossRef - Combining Nanotechnology and Gas Plasma as an Emerging Platform for Cancer Therapy: Mechanism and Therapeutic Implication
Milad Rasouli et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef - A modular ROS-responsive platform co-delivered by 10-hydroxycamptothecin and dexamethasone for cancer treatment
Qingye Meng et al, 2021, Journal of Controlled Release CrossRef - Current Understandings and Clinical Translation of Nanomedicines for Breast Cancer Therapy
Yike Jiang et al, 2021, Advanced Drug Delivery Reviews CrossRef - Carrier-free nanomedicines for cancer treatment
Li-Han Liu et al, 2022, Progress in Materials Science CrossRef - null
Ruiwu Liu et al, 2011 CrossRef - null
Coralie Deladriere et al, 2011 CrossRef - Tumor Stimulus-Responsive Biodegradable Diblock Copolymer Conjugates as Efficient Anti-Cancer Nanomedicines
Vladimír Šubr et al, 2022, JPM CrossRef - Increasing the Tumoricidal Activity of Daunomycin-pHPMA Conjugates Using Vitamin B12 as a Targeting Agent
null Gregory Russell-Jones et al, 2012, J. Can. Res. Updates CrossRef - Cathepsin B-responsive prodrugs for cancer-targeted therapy: Recent advances and progress for clinical translation
Seong Ik Jeon et al, 2022, Nano Res. CrossRef - Metabolic and non-metabolic pathways that control cancer resistance to anthracyclines
Tânia Capelôa et al, 2020, Seminars in Cell & Developmental Biology CrossRef - null
Zhiguo Wang et al, 2022 CrossRef - Gemigliptin exerts protective effects against doxorubicin-induced hepatotoxicity by inhibiting apoptosis via the regulation of fibroblast growth factor 21 expression
Kyeong-Min Lee et al, 2022, Biochemical and Biophysical Research Communications CrossRef - Poly(2-oxazoline) – Ferrostatin-1 drug conjugates inhibit ferroptotic cell death
Joshua P. Morrow et al, 2022, Journal of Controlled Release CrossRef - Challenging the fundamental conjectures in nanoparticle drug delivery for chemotherapy treatment of solid cancers
Juanjuan Yang et al, 2022, Advanced Drug Delivery Reviews CrossRef - Opportunities and Challenges of Switchable Materials for Pharmaceutical Use
Deniz Ceylan Tuncaboylu et al, 2022, Pharmaceutics CrossRef - null
Ankita Dadwal et al, 2023 CrossRef - null
C. Sarath Chandran et al, 2023 CrossRef - The multifaceted roles of tumor-associated proteases and harnessing their activity for prodrug activation
Olga Vasiljeva et al, 2019 CrossRef - Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting
Jihoon Lee et al, 2023, Pharmaceuticals CrossRef - Rational design of oral delivery nanosystems for hypoglycemic peptides
Taoxing Peng et al, 2023, Nano Today CrossRef - Exosomes as efficient platforms for delivering adenosine-tetra peptide conjugate to pancreatic cancer cells: An in vitro/in silico study
Pardis Ahmadi et al, 2023, Journal of Drug Delivery Science and Technology CrossRef -
In vitro studies of titanium dioxide nanoparticles modified with glutathione as a potential drug delivery system
Jolanta Pulit-Prociak et al, 2023 CrossRef - 10-hydroxycamptothecin-loaded starch-based microcapsules with the stepwise responsive release strategy for targeted controlled release
Qingye Meng et al, 2023, International Journal of Biological Macromolecules CrossRef - New opportunities and old challenges in the clinical translation of nanotheranostics
Peter J. Gawne et al, 2023, Nat Rev Mater CrossRef - Cancer nanomedicine: Recent developments in drug delivery systems and strategies to overcome eventual barriers to achieve a better outcome
Jeferson Gustavo Henn et al, 2023, Journal of Drug Delivery Science and Technology CrossRef - Doxorubicin conjugates: a practical approach for its cardiotoxicity alleviation
Abed Alqader Ibrahim et al, 2024, Expert Opinion on Drug Delivery CrossRef - Structural optimization of diblock polymers that undergo thermo-responsive nanoparticle self-assembly for intravitreal drug delivery
Kyle J. Fergie et al, 2024, European Polymer Journal CrossRef - Hydrophilic biomaterials: From crosslinked and self-assembled hydrogels to polymer-drug conjugates and drug-free macromolecular therapeutics
Jindřich Kopeček, 2024, Journal of Controlled Release CrossRef